Extracorporeal Membrane Oxygenation Machine (ECMO) Machine Market Report 2026

The extracorporeal membrane oxygenation machine (ecmo) machine market size has grown strongly in recent years. It will grow from $1.15 billion in 2025 to $1.24 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to increasing prevalence of respiratory failure, growth in cardiac disorders, expansion of intensive care units, rising use during pandemics, advancements in life-support technologies.

The extracorporeal membrane oxygenation machine (ecmo) machine market size is expected to see strong growth in the next few years. It will grow to $1.69 billion in 2030 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to technological advancements in oxygenators, rising investment in critical care infrastructure, increasing neonatal survival rates, expansion of mobile ecmo adoption, growing training programs for ecmo specialists. Major trends in the forecast period include rising use in critical care and emergency settings, growing adoption in neonatal and pediatric care, expansion of mobile ecmo systems, increased focus on advanced life support, growth in specialized ecmo centers.

The increase in lung transplant procedures is expected to drive the growth of the extracorporeal membrane oxygenation (ECMO) machine market. A lung transplant is a surgical procedure in which a diseased or damaged lung is replaced with a healthy lung from a donor. The number of lung transplants is rising due to advancements in surgical techniques, improved post-transplant care, and a growing organ donor pool, resulting in higher success rates and increased patient eligibility. ECMO machines support lung transplant procedures by providing life-saving respiratory and circulatory support to patients with severe respiratory failure, keeping them stable until a suitable donor lung becomes available. For instance, in January 2025, according to the Organ Procurement and Transplantation Network (OPTN), a US-based public-private partnership, lung transplants increased from 3,026 in 2023 to 3,340 in 2024, marking a 10.4% rise. Therefore, the rise in lung transplant procedures is propelling the growth of the ECMO machine market.

Major companies operating in the ECMO machine market are focusing on developing innovative products such as configurable one-system ECMO solutions to enhance patient outcomes, streamline clinical workflows, and improve ease of use in critical care settings. A configurable one-system ECMO solution is a flexible ECMO machine that can be tailored to individual patient needs, offering customizable settings and components for optimal respiratory and cardiac support in various clinical scenarios. For instance, in September 2024, Medtronic plc, a US-based medical device company, launched VitalFlow, a configurable ECMO solution designed for simplicity and high performance. This one-system solution allows for streamlined setup and easy adjustments during critical care, providing advanced monitoring capabilities to ensure optimal oxygenation and blood circulation. The system supports both venovenous (VV) and venoarterial (VA) configurations, making it adaptable to a wide range of patient requirements.

In March 2024, Medtronic plc, a US-based medical device company, acquired MC3 Cardiopulmonary for an undisclosed amount. This acquisition enables Medtronic to expand its portfolio of advanced life-support solutions by integrating ECMO technologies, enhancing its critical care capabilities, and offering innovative products for patients with severe heart and lung failure. MC3 Cardiopulmonary is a US-based company specializing in the development and manufacturing of advanced medical devices, including ECMO systems.

Major companies operating in the extracorporeal membrane oxygenation machine (ecmo) machine market are Abiomed Inc., Abbott Laboratories, Medtronic plc, Fresenius Medical Care AG & Co. KGaA, Terumo Cardiovascular Systems Corporation, Shenzhen Mindray Biomedical Electronics Co. Ltd., Nipro Corporation, Getinge Group, LivaNova plc, MicroPort Scientific Corporation, Hamilton Medical AG, Braile Biomédica, Xenios AG, Eurosets S.R.L., OriGen Biomedical Inc., Hemovent GmbH, Senko Medical Instrument Mfg Co Ltd, Medos Medizintechnik AG, Spectrum Medical, Chalice Medical.

North America was the largest region in the extracorporeal membrane oxygenation machine (ECMO) machine market in 2025. The regions covered in the extracorporeal membrane oxygenation machine (ecmo) machine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the extracorporeal membrane oxygenation machine (ecmo) machine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have impacted the extracorporeal membrane oxygenation machine market by increasing the cost of imported components such as oxygenators, pumps, and controllers, thereby raising overall manufacturing and procurement expenses. This has affected hospitals, ambulatory surgical centers, and research institutions the most, with Asia-Pacific and North America being particularly sensitive due to their dependence on cross-border medical device supply chains. Segments such as digital controllers, hollow fiber oxygenators, and centrifugal pumps have experienced higher price volatility. However, tariffs have also encouraged local manufacturing, supplier diversification, and regional production investments, which may improve long-term supply stability and competitiveness in the market.

The extracorporeal membrane oxygenation machine (ecmo) machine market research report is one of a series of new reports that provides extracorporeal membrane oxygenation machine (ecmo) machine market statistics, including extracorporeal membrane oxygenation machine (ecmo) machine industry global market size, regional shares, competitors with a extracorporeal membrane oxygenation machine (ecmo) machine market share, detailed extracorporeal membrane oxygenation machine (ecmo) machine market segments, market trends and opportunities, and any further data you may need to thrive in the extracorporeal membrane oxygenation machine (ecmo) machine industry. This extracorporeal membrane oxygenation machine (ecmo) machine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

An extracorporeal membrane oxygenation (ECMO) machine is a specialized medical device that provides cardiac and respiratory support by oxygenating blood outside the body. It is used for patients with severe heart or lung failure, offering critical support in life-threatening situations.

The main components of an ECMO machine include pumps, oxygenators, controllers, cannulas, and accessories. ECMO pumps circulate blood through the oxygenator, helping maintain blood flow during respiratory or cardiac failure, and are essential for ensuring adequate circulation during ECMO procedures. ECMO can be configured in veno-venous (VV), veno-arterial (VA), and arterio-venous (AV) modalities, each addressing different clinical requirements. The system is used for patient populations including neonates, pediatrics, and adults and is applied in the treatment of respiratory and cardiac conditions. End users of ECMO machines include hospitals, ambulatory surgical centers, and research institutions.

The extracorporeal membrane oxygenation (ECMO) machine market consists of sales of advanced life-support systems, monitoring systems, blood pumps, and consumables. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.